Article ID Journal Published Year Pages File Type
11019366 International Immunopharmacology 2018 7 Pages PDF
Abstract
CD105 is a promising biomarker for identification of RPA/MPA from PA cases. Ligand nABPK296 provides a promising approach to CD105 detection. This study also validated the reliability of phage display technology in finding new episodes and ligands with high affinity for antigens.
Keywords
Related Topics
Life Sciences Immunology and Microbiology Immunology
Preview
A new ligand of CD105 screened out by phage display technology provides a reliable identification of recurrent or metastasizing pleomorphic adenoma from pleomorphic adenoma
Authors
, , , , , ,